Evidence map›Paper›PMID 29627513›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2018

High level efficacy of lufenuron against sea lice (Lepeophtheirus salmonis) linked to rapid impact on moulting processes.

Jordan D Poley, Laura M Braden, Amber M Messmer, Okechukwu O Igboeli, Shona K Whyte, Alicia Macdonald, Jose Rodriguez, Marta Gameiro, Lucien Rufener, Jacques Bouvier and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jordan D PoleyHoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: jpoley@upei.ca.
Laura M BradenHoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: lbraden@upei.ca.
Amber M MessmerCentre for Biomedical Research, Department of Biology, University of Victoria, Victoria BC, V8W 3N5, Canada. Electronic address: amessmer@uvic.ca.
Okechukwu O IgboeliHoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: oigboeli@gmail.com.
Shona K WhyteHoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: swhyte@upei.ca.
Alicia MacdonaldElanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: alicia.macdonald@elanco.com.
Jose RodriguezElanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: jose.rodriguez@elanco.com.
Marta GameiroElanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: marta.gameiro@elanco.com.
Lucien RufenerElanco Centre de Recherche Santé Animale SA, CH-1566 St.-Aubin, Switzerland; INVENesis LLC, Chemin de Belleroche 14, 2000 Neuchâtel, Switzerland. Electronic address: lucien.rufener@elanco.com.
Jacques BouvierElanco Centre de Recherche Santé Animale SA, CH-1566 St.-Aubin, Switzerland; INVENesis LLC, Chemin de Belleroche 14, 2000 Neuchâtel, Switzerland. Electronic address: jacques.bouvier@elanco.com.
Dorota W WadowskaElectron Microscopy Laboratory, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown, PEI, C1A 4P3, Canada. Electronic address: Wadowska@upei.ca.
Ben F KoopCentre for Biomedical Research, Department of Biology, University of Victoria, Victoria BC, V8W 3N5, Canada. Electronic address: bkoop@uvic.ca.
Barry C HoskingElanco Canada Limited, 150 Research Lane, Guelph, Ontario N1G 4T2, Canada. Electronic address: barry.hosking@elanco.com.
Mark D FastHoplite Lab, Department of Pathology & Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Ave, Charlottetown PE, C1A 4P3, Canada. Electronic address: mfast@upei.ca.
University of Prince Edward Island · CAUniversity of Victoria · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug resistance in the salmon louse Lepeophtheirus salmonis is a global issue for Atlantic salmon aquaculture. Multiple resistance has been described across most available compound classes with the exception of the benzoylureas. To target this gap in effective management of L. salmonis and other species of sea lice (e.g. Caligus spp.), Elanco Animal Health is developing an in-feed treatment containing lufenuron (a benzoylurea) to be administered prior to seawater transfer of salmon smolts and to provide long-term protection of salmon against sea lice infestations. Benzoylureas disrupt chitin synthesis, formation, and deposition during all moulting events. However, the mechanism(s) of action are not yet fully understood and most research completed to date has focused on insects. We exposed the first parasitic stage of L. salmonis to 700 ppb lufenuron for three hours and observed over 90% reduction in survival to the chalimus II life stage on the host, as compared to vehicle controls. This agrees with a follow up in vivo administration study on the host, which showed >95% reduction by the chalimus I stage. Transcriptomic responses of salmon lice exposed to lufenuron included genes related to moulting, epithelial differentiation, solute transport, and general developmental processes. Global metabolite profiles also suggest that membrane stability and fluidity is impacted in treated lice. These molecular signals are likely the underpinnings of an abnormal moulting process and cuticle formation observed ultrastructurally using transmission electron microscopy. Treated nauplii-staged lice exhibited multiple abnormalities in the integument, suggesting that the coordinated assembly of the epi- and procuticle is impaired. In all cases, treatment with lufenuron had rapid impacts on L. salmonis development. We describe multiple experiments to characterize the efficacy of lufenuron on eggs, larvae, and parasitic stages of L. salmonis, and provide the most comprehensive assessment of the physiological responses of a marine arthropod to a benzoylurea chemical.

Indexed as

AnimalsAquacultureBenzamidesFish DiseasesFluorocarbonsLice InfestationsLife Cycle StagesMetabolomicsMoltingPhthirapteraSalmo salarSeawaterTranscriptomeBenzamidesFluorocarbonsfluphenacurAquacultureBenzoylureaLufenuronMoultingSea liceTranscriptomics

Identifiers

PMID29627513
PMCPMC6039351
OpenAlexW2793565528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.